Anna Hirschberger

A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity.

R. Braren, B. Wollenberg, P. Knolle, 2023, Cancer cell.

Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses.

D. Schadendorf, A. Krüger, A. Obenauf, 2023, Immunity.

PGE2 limits effector expansion of tumour-infiltrating stem-like CD8+ T cells

P. Knolle, F. Bayerl, D. Zehn, 2024, Nature.